Induction chemotherapy for unresectable urothelial carcinoma of the bladder

BJU International

Volumn 107, Issue 6, 2011, Pages 894-897

  Ghadjar, Pirus ^a   Burkhard, Fiona C ^a   Gautschi, Oliver ^a   Thalmann, George N ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bladder cancer; Chemotherapy; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; CYSTECTOMY; DEOXYCYTIDINE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; REMISSION INDUCTION; URINARY BLADDER NEOPLASMS;

EID: 79952603248     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09574.x     Document Type: Article

References (9)

1. Advanced Bladder Cancer (ABC) Metaanalysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systemic review and metaanalysis of individual patient data. Eur Urol 2005; 48: 202-5
2. Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-66 (Pubitemid 37025405)
3. Dash A, Pettus JA, Herr HW et al. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer 2008; 113: 2471-7
4. Weight CJ, Garcia JA, Hansel DE et al. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer 2009; 115: 792-9
5. Sobin LH, Wittekind CH, Sobin LH, Wittekind CH eds. TNM Classification of Malignant Tumors. New York: Wiley-Liss, 2002
6. Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690-6 (Pubitemid 46621904)
7. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-4
8. Advanced Bladder Cancer (ABC) Metaanalysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 189-99
9. Madersbacher S, Thalmann GN, Fritsch JC, Studer UE. Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? J Clin Oncol 2004; 22: 4103-8 (Pubitemid 41185179)